Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets for the year ending December 31, 2023: USD 420.70 M

Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets is USD 420.70 M for the year ending December 31, 2023, a -22.52% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 542.96 M, a 63.86% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 331.36 M, a 46.99% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 225.44 M, a 12.21% change year over year.
Shanghai Labway Clinical Laboratory Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 200.90 M, a -4.26% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years